* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
4907	NT5E	C1859372	Calcification of Joints and Arteries	0.600549453568426	BEFREE;CTD_human;ORPHANET;UNIPROT
4907	NT5E	C0022408	Arthropathy	0.2	HPO
4907	NT5E	C0023893	Liver Cirrhosis, Experimental	0.2	CTD_human
4907	NT5E	C0029396	Heterotopic Ossification	0.2	HPO
4907	NT5E	C0038356	Stomach Neoplasms	0.2	CTD_human
4907	NT5E	C0240083	joint abnormality	0.2	HPO
4907	NT5E	C1168153	arterial calcification	0.2	HPO
4907	NT5E	C4020882	Abnormality of the backbone	0.2	HPO
4907	NT5E	C4020899	Autosomal recessive predisposition	0.2	HPO
4907	NT5E	C4021789	Abnormality of the vertebral column	0.2	HPO
4907	NT5E	C0025202	melanoma	0.0060152784980537	BEFREE;LHGDN
4907	NT5E	C1458155	Mammary Neoplasms	0.0057405517138406	BEFREE;LHGDN
4907	NT5E	C0023434	Chronic Lymphocytic Leukemia	0.00355709281745305	BEFREE;LHGDN
4907	NT5E	C1140680	Malignant neoplasm of ovary	0.0032312088759273	BEFREE;GAD
4907	NT5E	C0027627	Neoplasm Metastasis	0.0030219946263441	BEFREE
4907	NT5E	C0026769	Multiple Sclerosis	0.00273291246481375	LHGDN
4907	NT5E	C0015672	Fatigue	0.0026817553075011	BEFREE;GAD
4907	NT5E	C0009404	Colorectal Neoplasms	0.002407028523288	GAD
4907	NT5E	C0021603	Sleep Initiation and Maintenance Disorders	0.002407028523288	GAD
4907	NT5E	C0851578	Sleep Disorders	0.002407028523288	GAD
4907	NT5E	C0006142	Malignant neoplasm of breast	0.0021978142737048	BEFREE
4907	NT5E	C0678222	Breast Carcinoma	0.0021978142737048	BEFREE
4907	NT5E	C0023467	Leukemia, Myelocytic, Acute	0.0008241803526393	BEFREE
4907	NT5E	C0029925	Ovarian Carcinoma	0.0008241803526393	BEFREE
4907	NT5E	C0178874	Tumor Progression	0.0008241803526393	BEFREE
4907	NT5E	C0002878	Anemia, Hemolytic	0.0005494535684262	BEFREE
4907	NT5E	C0010346	Crohn Disease	0.0005494535684262	BEFREE
4907	NT5E	C0017638	Glioma	0.0005494535684262	BEFREE
4907	NT5E	C0021400	Influenza	0.0005494535684262	BEFREE
4907	NT5E	C0025149	Medulloblastoma	0.0005494535684262	BEFREE
4907	NT5E	C0278488	Carcinoma breast stage IV	0.0005494535684262	BEFREE
4907	NT5E	C1292769	Precursor B-cell lymphoblastic leukemia	0.0005494535684262	BEFREE
4907	NT5E	C0003504	Aortic Valve Insufficiency	0.0002747267842131	BEFREE
4907	NT5E	C0003850	Arteriosclerosis	0.0002747267842131	BEFREE
4907	NT5E	C0004153	Atherosclerosis	0.0002747267842131	BEFREE
4907	NT5E	C0004352	Autistic Disorder	0.0002747267842131	BEFREE
4907	NT5E	C0004364	Autoimmune Diseases	0.0002747267842131	BEFREE
4907	NT5E	C0005684	Malignant neoplasm of urinary bladder	0.0002747267842131	BEFREE
4907	NT5E	C0007102	Malignant tumor of colon	0.0002747267842131	BEFREE
4907	NT5E	C0007103	Malignant neoplasm of endometrium	0.0002747267842131	BEFREE
4907	NT5E	C0007570	Celiac Disease	0.0002747267842131	BEFREE
4907	NT5E	C0008354	Cholera	0.0002747267842131	BEFREE
4907	NT5E	C0009319	Colitis	0.0002747267842131	BEFREE
4907	NT5E	C0009324	Ulcerative Colitis	0.0002747267842131	BEFREE
4907	NT5E	C0009402	Colorectal Carcinoma	0.0002747267842131	BEFREE
4907	NT5E	C0010823	Cytomegalovirus Infections	0.0002747267842131	BEFREE
4907	NT5E	C0011608	Dermatitis Herpetiformis	0.0002747267842131	BEFREE
4907	NT5E	C0014378	Enterovirus Infections	0.0002747267842131	BEFREE
4907	NT5E	C0017152	Gastritis	0.0002747267842131	BEFREE
4907	NT5E	C0017551	Gilbert Disease (disorder)	0.0002747267842131	BEFREE
4907	NT5E	C0019693	HIV Infections	0.0002747267842131	BEFREE
4907	NT5E	C0020473	Hyperlipidemia	0.0002747267842131	BEFREE
4907	NT5E	C0020538	Hypertensive disease	0.0002747267842131	BEFREE
4907	NT5E	C0023418	leukemia	0.0002747267842131	BEFREE
4907	NT5E	C0023890	Liver Cirrhosis	0.0002747267842131	BEFREE
4907	NT5E	C0024117	Chronic Obstructive Airway Disease	0.0002747267842131	BEFREE
4907	NT5E	C0024419	Waldenstrom Macroglobulinemia	0.0002747267842131	BEFREE
4907	NT5E	C0026838	Muscle Spasticity	0.0002747267842131	BEFREE
4907	NT5E	C0031117	Peripheral Neuropathy	0.0002747267842131	BEFREE
4907	NT5E	C0033578	Prostatic Neoplasms	0.0002747267842131	BEFREE
4907	NT5E	C0033847	Pseudoxanthoma Elasticum	0.0002747267842131	BEFREE
4907	NT5E	C0034063	Pulmonary Edema	0.0002747267842131	BEFREE
4907	NT5E	C0036572	Seizures	0.0002747267842131	BEFREE
4907	NT5E	C0037285	Skin Manifestations	0.0002747267842131	BEFREE
4907	NT5E	C0041296	Tuberculosis	0.0002747267842131	BEFREE
4907	NT5E	C0042769	Virus Diseases	0.0002747267842131	BEFREE
4907	NT5E	C0042974	von Willebrand Disease	0.0002747267842131	BEFREE
4907	NT5E	C0085084	Motor Neuron Disease	0.0002747267842131	BEFREE
4907	NT5E	C0149978	Adenocarcinoma of rectum	0.0002747267842131	BEFREE
4907	NT5E	C0153452	Malignant neoplasm of gallbladder	0.0002747267842131	BEFREE
4907	NT5E	C0221036	Acrodermatitis enteropathica	0.0002747267842131	BEFREE
4907	NT5E	C0235782	Gallbladder Carcinoma	0.0002747267842131	BEFREE
4907	NT5E	C0235974	Pancreatic carcinoma	0.0002747267842131	BEFREE
4907	NT5E	C0239946	Fibrosis, Liver	0.0002747267842131	BEFREE
4907	NT5E	C0242596	Neoplasm, Residual	0.0002747267842131	BEFREE
4907	NT5E	C0275911	Tuberculosis of intestines	0.0002747267842131	BEFREE
4907	NT5E	C0279651	Gallbladder adenocarcinoma	0.0002747267842131	BEFREE
4907	NT5E	C0280100	solid tumor	0.0002747267842131	BEFREE
4907	NT5E	C0346647	Malignant neoplasm of pancreas	0.0002747267842131	BEFREE
4907	NT5E	C0376358	Malignant neoplasm of prostate	0.0002747267842131	BEFREE
4907	NT5E	C0376545	Hematologic Neoplasms	0.0002747267842131	BEFREE
4907	NT5E	C0392607	Severe combined immunodeficiency due to adenosine deaminase deficiency	0.0002747267842131	BEFREE
4907	NT5E	C0393559	Troyer syndrome	0.0002747267842131	BEFREE
4907	NT5E	C0398686	Primary immune deficiency disorder	0.0002747267842131	BEFREE
4907	NT5E	C0443306	Spastic	0.0002747267842131	BEFREE
4907	NT5E	C0473583	Nevus elasticus	0.0002747267842131	BEFREE
4907	NT5E	C0476089	Endometrial Carcinoma	0.0002747267842131	BEFREE
4907	NT5E	C0520572	Enzymopathy	0.0002747267842131	BEFREE
4907	NT5E	C0600139	Prostate carcinoma	0.0002747267842131	BEFREE
4907	NT5E	C0677886	Epithelial ovarian cancer	0.0002747267842131	BEFREE
4907	NT5E	C0686377	CNS metastases	0.0002747267842131	BEFREE
4907	NT5E	C0686619	Secondary malignant neoplasm of lymph node	0.0002747267842131	BEFREE
4907	NT5E	C0699790	Colon Carcinoma	0.0002747267842131	BEFREE
4907	NT5E	C0848548	hypertensive nephropathy	0.0002747267842131	BEFREE
4907	NT5E	C0855095	Small Lymphocytic Lymphoma	0.0002747267842131	BEFREE
4907	NT5E	C0919267	ovarian neoplasm	0.0002747267842131	BEFREE
4907	NT5E	C0920646	Renal ischaemia	0.0002747267842131	BEFREE
4907	NT5E	C0948380	Colorectal cancer metastatic	0.0002747267842131	BEFREE
4907	NT5E	C1264606	Persistent infection	0.0002747267842131	BEFREE
4907	NT5E	C1291401	Phosphoribosylpyrophosphate synthetase deficiency	0.0002747267842131	BEFREE
4907	NT5E	C1527249	Colorectal Cancer	0.0002747267842131	BEFREE
4907	NT5E	C1561643	Chronic Kidney Diseases	0.0002747267842131	BEFREE
4907	NT5E	C1621958	Glioblastoma Multiforme	0.0002747267842131	BEFREE
4907	NT5E	C1623038	Cirrhosis	0.0002747267842131	BEFREE
4907	NT5E	C1800706	Idiopathic Pulmonary Fibrosis	0.0002747267842131	BEFREE
4907	NT5E	C1848745	Oliver-McFarlane syndrome	0.0002747267842131	BEFREE
4907	NT5E	C1859727	Arterial calcification of infancy	0.0002747267842131	BEFREE
4907	NT5E	C1883486	Uterine Corpus Cancer	0.0002747267842131	BEFREE
4907	NT5E	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	0.0002747267842131	BEFREE
4907	NT5E	C2239176	Liver carcinoma	0.0002747267842131	BEFREE
4907	NT5E	C3463824	MYELODYSPLASTIC SYNDROME	0.0002747267842131	BEFREE
4907	NT5E	C3539878	Triple Negative Breast Neoplasms	0.0002747267842131	BEFREE
4907	NT5E	C4025735	Nonspherocytic hemolytic anemia	0.0002747267842131	BEFREE